Ozempic

Ozempic

Product

by Novo Nordisk

Heard in 189 episodes across 101 shows since Oct 2025

Ozempic is a prescription injectable medicine containing semaglutide, a GLP-1 receptor agonist. It is used with diet and exercise to improve blood sugar in adults with type 2 diabetes and to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease; semaglutide can also suppress appetite and reduce body weight, although weight management is associated with the separate Wegovy brand.

Discussed inMarkets36%Health & Science21%Culture11%Politics10%

Episodes

189
across 101 shows

This week

0
episodes on 0 shows

Expert statements

6
5 positive · 1 negative

Share of the conversation

Mentions of Ozempic per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.2‰0.4‰0.6‰0.8‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Oct 120.14‰6
Oct 130.15‰2
Oct 150.15‰1
Oct 160.14‰3
Oct 170.15‰1
Oct 180.12‰1
Oct 190.09‰2
Oct 200.10‰4
Oct 210.12‰2
Oct 220.12‰1
Oct 230.11‰2
Oct 240.11‰2
Oct 250.12‰2
Oct 270.10‰3
Oct 280.11‰3
Oct 290.14‰4
Oct 300.13‰1
Oct 310.12‰1
Nov 10.13‰3
Nov 20.13‰1
Nov 30.17‰7
Nov 40.16‰2
Nov 50.15‰3
Nov 60.17‰3
Nov 70.16‰1
Nov 80.16‰3
Nov 90.22‰8
Nov 100.18‰3
Nov 110.18‰1
Nov 120.18‰2

The full trend: rank, tone and why it is trending →

Email alert

Email me when Ozempic comes up on a podcast

One email a week at most, with the new episodes that mention Ozempic. Free, no account needed, unsubscribe in one click.

What experts have said about Ozempic

6 statements · 5 positive · 1 negative

  1. Sean O'MaraNegativeOct 4, 2026· The Megyn Kelly Show

    Stopping Ozempic and GLP medications causes obesity, weight, and disease to return.

    “as soon as you stop taking it, every study shows that obesity returns, weight gain, disease gain”

    Listen at 4:18:55

    Open the episode · Get Healthy, with Gary Brecka, Andrew Huberman, and Sean O'Mara
  2. Chloe MelleyPositiveSep 8, 2026· Stock Movers

    Semaglutide patent expirations enable Sandoz to sell cheaper generic versions.

    “that's paving the way for generic drug companies like Sandoz to sell cheaper versions of this key ingredient”

    Listen at 3:16

    Open the episode · Novartis Slumps, Sandoz Gains, Computacenter Up
  3. Johann HariPositiveAug 14, 2026· Big Technology Podcast

    Ozempic reduced Hari’s intake and produced 42 pounds of first-year weight loss.

    “It's why I went from eating 3,200 calories a day to about 1,800. It's why I lost 42 pounds in the first year.”

    Listen at 17:01

    Open the episode · Best of Big Technology: How Ozempic Changes Our Bodies, Minds, and Economy — With Johann Hari

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

189 episodes featuring Ozempic, newest first